-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Meet the Blood Editors (for in-person participants)

Program: Blood Journals Studio
Sunday, December 10, 2023: 10:00 AM-11:00 AM
Halls G-H - Blood Journals Studio (San Diego Convention Center)
Panelists:
Bertie Göttgens, PhD, University of Cambridge and Helen Elisabeth Heslop, Baylor College of Medicine
Disclosures:
Heslop: Tessa Therapeutics: Membership on an entity's Board of Directors or advisory committees, Other: Research Support; Marker Therapeutics: Current equity holder in private company, Membership on an entity's Board of Directors or advisory committees; Ankyra Therapeutics: Membership on an entity's Board of Directors or advisory committees; Allovir: Current equity holder in private company; Fresh Wind Biotechnologies: Current equity holder in private company; CoRegen Inc.: Current equity holder in private company.
This session provides attendees the opportunity to meet with the associate editors of Blood. Learn about recent changes to the journal as well as the submission and peer-review processes and policies. Seating is limited and available on a first-come, first-served basis.
See more of: Blood Journals Studio